tesamorelin / ipamorelin & Tesamorelin vs Ipamorelin: Benefits, Differences,

When tesamorelin is the more appropriate choice Tesamorelin is typically the preferred agent when: Visceral adipose tissue is the primary treatment target, particularly with associated metabolic comorbidities A clinician is working within a framework that prioritises FDA-approved agents The patient has HIV-associated lipodystrophy, the only approved indication A robust evidence base is required for clinical decision-making For general somatopause-related concerns gradual changes in body composition, sleep quality, and recovery the CJC-1295/ipamorelin combination remains more commonly used, primarily because of its flexible dosing profile and the preserved pulsatile GH release pattern

Due to this, Ipamorelin comes with the benefits of other peptides without the negative side effects, avoiding the spiking of blood sugar and bone depleting effects of other similar substances

Esto la hace muy segura (difcil de sobredosificar), pero a veces limita su potencia mxima si tus niveles de somatostatina son altos

Choose the reconstitution volume that yields the working concentration your protocol calls for

However, their mechanisms and benefits make them suitable for different goals

With DAC: 1-2x weekly (due to long half-life)